ANTIKÖRPER GEGEN CSF-1R

Patent europeic · EP3549599 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3549599
Numer da la dumonda
EP19171833
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
26-08-2014
Publitgà
09-10-2019
Concedì
06-09-2023
La protecziun finescha il pli tard
25-08-2034
Proxima taxa annuala scadenta
31-08-2027
Classas IPC
A61K 39/00 (2006.01)
A61P 11/00 (2006.01)
A61P 35/00 (2006.01)
C07K 16/28 (2006.01)
Prioritad
GB 201315487 30.08.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-09-2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. 01-09-2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. 03-09-2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 03.09.2024

  4. 17-07-2024

    Midada

    Published in Swissreg on 17.07.2024

  5. 06-09-2023

    Concedì

    Published in Swissreg on 06.09.2023

Partidas

Possessur

UCB Biopharma SRL

Allée de la Recherche 60, 1070 Brussels, BE

Inventur

HERVÉ, Karine Jeannine Madeleine

Slough, Berkshire SL1 3WE, GB

MARSHALL, Diane

Slough, Berkshire SL1 3WE, GB

CRAGGS, Graham

Slough, Berkshire SL1 3WE, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.